Categories: News

AgriCann Announces Resignation of Chief Executive Officer

Vancouver, British Columbia–(Newsfile Corp. – December 13, 2023) – AgriCann Solutions Corp. (AgriCann“) (with its subsidiaries, collectively referred to as “the Company“) announces the voluntary resignation of Adam Sancewicz from the position of Chief Executive Officer of Agricann effective immediately, along with his positions held in subsidiaries Newline Ventures Inc. and Craft Nurseries Canada Ltd., pending completion of certain assignments, transfers and records in compliance with Health Canada and other regulatory requirements. Sancewicz has served as President since August 2022 and as CEO since April 2023.

“We thank Adam for his leadership and guidance during the Company’s restructuring of its Craft Nurseries operations, and the transition to and recent acquisition of Newline Ventures,” said Rob van Santen, AgriCann’s Chairman. “We wish him all the best in his future endeavours.”

AgriCann has appointed Tim Tombe as interim CEO. Tim is a director of AgriCann, remains the Company’s largest shareholder, and was co-founder and a former director of Valens AgriTech Ltd. and its parent company The Valens Company, recently acquired by Nasdaq-listed SNDL Inc.

About AgriCann Solutions Corp.

AgriCann operates wholly owned subsidiaries Craft Nurseries Canada Ltd., a full-service Health Canada licenced cannabis nursery located in Lake Country, and Newline Ventures Inc., a Health Canada multi-licenced facility in nearby Vernon, British Columbia.

AgriCann supports craft cultivators through innovative marketing initiatives, creating demand with premium genetics and strong consumer branding, and facilitates the distribution of consumer-packaged goods through scalable logistics models. By providing cultivating partners with access to superior genetics, starting materials, and cultivation support, we ensure quality control of finished flower as a trusted partner enabling effective and strategic competition in today’s market. AgriCann provides a logistics solution by helping micro-batch craft cultivators build a viable business, getting their products to market efficiently and thereby securing a reliable supply of premium craft cannabis products to domestic and global markets.

AgriCann Solutions’ website: https://agricannsolutions.com/

Craft Nurseries’ website: https://www.craftnurseries.com/

ON BEHALF OF AGRICANN SOLUTIONS CORP.

(signed) “Rob van Santen”
Executive Chairman

For further information, please contact:

Bobby Athwal
Chief Operating Officer
Telephone: +1.905.621.2104

Cautionary Note Regarding Forward-Looking Statements

Some of the statements contained in this press release are forward-looking statements and information within the meaning of applicable securities laws. Forward-looking statements and information can be identified by the use of words such as “expects”, “believe”, “intends”, “is expected”, “is likely”, “potential”, “suggests” or variations of such words or phrases, or statements that certain actions, events or results “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements and information are not historical facts and are subject to a number of risks and uncertainties beyond the Company’s control. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by applicable law.

AgriCann Solutions Corp.
400-1771 Robson Street, Vancouver, BC, Canada V6G1C9
Tel. +1.604.608.1999 ~ Fax. +1.778.379.9990

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/190911

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

2 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

2 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

2 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

2 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

2 hours ago